Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of STM-416p in patients undergoing radical prostatectomy for prostate cancer. The study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STM-416p

Snippet

Sponsor: SURGE Therapeutics | Conditions: Prostate Cancer | Phase 1 | Status: RECRUITING